Session 4: Should I start a company?
Sponsored by
Vignette: Approaches to Participating in Innovation Beyond Technology Development
Erik Andersen, MS, BSN, RN
Clinical Liaison, WakeMed Innovations
Principle Consultant, Andersen Innovations
Becky Fox, RN-BC
Vice President, Chief Nursing Informatics Officer, Atrium Health
Sandeep Grewal, MD
Hospitalist Physician, NovantHealth.
Leader, AI Telemetry Project, NovantHealth
Janet Harris-Hicks, MD
Urogynecologist, FirstHealth Urogynecology
Physician, FirstHealth of the Carolinas
Session 4: Should I start a company?
Session summary: A general misconception is that if one is developing a new technology, a start-up company should be formed. But that is not necessarily the case. This session explores different paths that can be taken to develop technology and get it into the hands of the end user, including licensing, product acquisition, company formation and exit strategy. Important considerations that will be discussed are career interests of the clinician innovator (i.e., run a company vs practice medicine) and how the type of technology and its commercial potential can influence the path taken. If start-up company formation is the right path, what are key considerations in structuring a company?
Moderator:
Meg Powell, PharmD
CEO, 501 Ventures, LLC
Panelists:
Mike Carnes
Technology Commercialization Counselor & Equity Funding Specialist, NC Small Business and Technology Development Center (NC SBTDC)
Krista Covey
President, First Flight Venture Center
Travis Manasco, MD
CMO, Bio 54, LLC
Emergency Medicine & Intensive Care Physician, WakeMed Health and Hospitals
Ken Russell
Director of Technology Development, Wake Forest School of Medicine